A&G Pharmaceutical and Celltrion Announce Bioprocess Development and Manufacturing Agreement

News   Jun 09, 2006

 
A&G Pharmaceutical and Celltrion Announce Bioprocess Development and Manufacturing Agreement
 
 
 

RELATED ARTICLES

Immune Cells Hold Promise In Slowing ALS

News

Recent research showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.

READ MORE

Single-injection Polio Vaccine

News

A new nanoparticle vaccine developed by MIT researchers could assist efforts to eradicate polio worldwide. The vaccine, which delivers multiple doses in just one injection, could make it easier to immunize children in remote regions of Pakistan and other countries where the disease is still found.

READ MORE

Infection Blood Test of Limited Value in Reducing Antibiotic Use

News

Overall antibiotic use was not curbed by giving physicians the results of biomarker tests in patients with suspected lower respiratory tract infections, according to findings from the Procalcitonin Antibiotic Consensus Trial (ProACT).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE